PL3572405T3 - Amidy benzoimidazol-1,2-ylowe jako aktywatory kanału kv7 - Google Patents

Amidy benzoimidazol-1,2-ylowe jako aktywatory kanału kv7

Info

Publication number
PL3572405T3
PL3572405T3 PL19185319.1T PL19185319T PL3572405T3 PL 3572405 T3 PL3572405 T3 PL 3572405T3 PL 19185319 T PL19185319 T PL 19185319T PL 3572405 T3 PL3572405 T3 PL 3572405T3
Authority
PL
Poland
Prior art keywords
benzoimidazol
amides
channel activators
activators
channel
Prior art date
Application number
PL19185319.1T
Other languages
English (en)
Inventor
Lynn Resnick
George T Topalov
Steven A. Boyd
Justin K. Belardi
Charles A. Flentge
James S. Hale
Scott S. Harried
David A. Mareska
Kai Zhang
Original Assignee
Biohaven Therapeutics Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohaven Therapeutics Ltd. filed Critical Biohaven Therapeutics Ltd.
Publication of PL3572405T3 publication Critical patent/PL3572405T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL19185319.1T 2014-09-12 2015-09-14 Amidy benzoimidazol-1,2-ylowe jako aktywatory kanału kv7 PL3572405T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462050023P 2014-09-12 2014-09-12

Publications (1)

Publication Number Publication Date
PL3572405T3 true PL3572405T3 (pl) 2023-11-13

Family

ID=55454102

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19185319.1T PL3572405T3 (pl) 2014-09-12 2015-09-14 Amidy benzoimidazol-1,2-ylowe jako aktywatory kanału kv7

Country Status (14)

Country Link
US (6) US9481653B2 (pl)
EP (3) EP4289822A3 (pl)
DK (2) DK3572405T3 (pl)
ES (2) ES2960991T3 (pl)
FI (1) FI3572405T3 (pl)
HR (1) HRP20231071T1 (pl)
HU (1) HUE064331T2 (pl)
LT (1) LT3572405T (pl)
PL (1) PL3572405T3 (pl)
PT (1) PT3572405T (pl)
RS (1) RS64708B1 (pl)
SI (1) SI3572405T1 (pl)
SM (1) SMT202300362T1 (pl)
WO (2) WO2016040952A2 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2970277B1 (en) * 2013-03-15 2021-07-28 Knopp Biosciences LLC Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators
SMT202300362T1 (it) 2014-09-12 2023-11-13 Biohaven Therapeutics Ltd Benzoimidazol-1,2-il-ammidi come attivatori di canale kv7
ES3032221T3 (en) * 2018-02-20 2025-07-16 H Lundbeck As Alcohol derivatives as kv7 potassium channel openers
US10590067B2 (en) 2018-02-20 2020-03-17 H. Lundbeck A/S Alcohol derivatives of carboxamides as Kv7 potassium channel openers
CA3093976A1 (en) * 2018-03-19 2019-09-26 Michael E. Bozik Kv7 channel activators compositions and methods of use
MX2022001063A (es) * 2019-08-02 2022-02-14 H Lundbeck As Derivados de alcohol como abridores del canal de potasio kv7.
JP7591036B2 (ja) 2019-08-02 2024-11-27 ハー・ルンドベック・アクチエゼルスカベット てんかん又はてんかん発作において使用するためのKv7カリウムチャネル開口薬としてのアルコール誘導体
AR119521A1 (es) 2019-08-02 2021-12-22 H Lundbeck As DERIVADOS DE ALCOHOL COMO ABRIDORES DEL CANAL DE POTASIO Kv7
US20220227716A1 (en) * 2019-08-28 2022-07-21 Ferro Therapeutics, Inc. Benzimidazole and hydrogenated carbazole derivatives as gpx4 inhibitors
EP4031548A4 (en) * 2019-09-17 2023-10-18 Knopp Biosciences LLC Methods of use for kv7 channel activators
WO2023133256A1 (en) * 2022-01-07 2023-07-13 Biohaven Therapeutics Ltd. Pyrazolo[1,5-a]pyridin-2,3-yl amides as kv7 channel activators
EP4584250A4 (en) * 2022-09-06 2026-02-25 Biohaven Therapeutics Ltd POLYTHERAPIES INCLUDING METAL CHANNEL ACTIVATORS
WO2025103406A1 (zh) * 2023-11-15 2025-05-22 南京明德新药研发有限公司 6并5杂芳基衍生物及其应用
WO2026042005A1 (en) 2024-08-18 2026-02-26 Biohaven Therapeutics Ltd. Prodrugs of benzimidazol-1,2-yl amide compounds

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1022554A (en) 1973-03-07 1977-12-13 Haukur Kristinsson 1-carbamoyl-2-alkoxycarbonylaminoimidazo (4,5-b) pyridines
US4002623A (en) 1974-08-07 1977-01-11 Pfizer Inc. Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines
ES473201A1 (es) 1977-09-26 1979-03-16 Degussa Procedimiento para la preparacion de 7-azabencimidazoles
US4391811A (en) 1981-10-02 1983-07-05 Sterling Drug Inc. 2-Amino-6-(pyridinyl)-3H-imidazo[4,5-b]pyridines and their cardiotonic use
JPH0772181B2 (ja) * 1989-06-26 1995-08-02 株式会社大塚製薬工場 ベンズイミダゾール誘導体
JPH0772181A (ja) 1993-09-03 1995-03-17 Advantest Corp 電位波形測定方法および装置
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
KR100547929B1 (ko) 1997-09-26 2006-02-02 젠타리스 게엠베하 세린/트레오닌 단백질 키나제 기능을 조절하기 위한 아자벤즈이미다졸계 화합물, 이의 제조방법 및 이를 포함하는 약제학적 조성물
US20030109549A1 (en) * 1999-08-05 2003-06-12 Fumitaka Ito 2-Substituted-1-piperidyl benzimidazole compounds as ORL1-receptor agonists
JP2001199968A (ja) 2000-01-18 2001-07-24 Teijin Ltd アミノベンズイミダゾール誘導体
US6384049B1 (en) 2000-05-25 2002-05-07 The Procter & Gamble Company Cancer treatment
US6855714B2 (en) * 2001-07-06 2005-02-15 Schering Aktiengesellschaft 1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
FR2846656B1 (fr) 2002-11-05 2004-12-24 Servier Lab Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
SE0301701D0 (sv) * 2003-06-10 2003-06-10 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO2005021547A2 (en) 2003-08-28 2005-03-10 Pharmaxis Pty Ltd. Heterocyclic cannabinoid cb2 receptor antagonists
KR20070092297A (ko) 2004-12-21 2007-09-12 데브젠 엔브이 Kv4 이온 채널 활성을 갖는 화합물
US20080146536A1 (en) 2005-08-16 2008-06-19 Pharmacopeia, Inc. 2-Aminoimidazopyridines for treating neurodegenerative diseases
ES2274712B1 (es) 2005-10-06 2008-03-01 Laboratorios Almirall S.A. Nuevos derivados imidazopiridina.
US8288393B2 (en) 2007-08-10 2012-10-16 Nippon Soda Co., Ltd. Nitrogen-containing heterocyclic compound and pest control agent
EP2178373B1 (en) 2007-08-17 2013-01-23 Icagen, Inc. Heterocycles as potassium channel modulators
JP5479912B2 (ja) * 2007-11-22 2014-04-23 全薬工業株式会社 複素環式化合物の非晶質体、それを含む固体分散体、薬剤、およびその製造法
GB0723794D0 (en) 2007-12-05 2008-01-16 Lectus Therapeutics Ltd Potassium ion channel modulators and uses thereof
JP5520831B2 (ja) * 2007-12-19 2014-06-11 アムジエン・インコーポレーテツド Pi3キナーゼの阻害薬
US20110269783A1 (en) * 2008-11-10 2011-11-03 Neurosearch A/S Novel 2,3-diamino-quinazolinone derivatives and their medical use
PE20120334A1 (es) * 2008-12-19 2012-04-16 Abbott Lab COMPUESTOS HETEROCICLICOS INHIBIDORES DE LAS PROTEINAS ANTI-APOPTOTICAS Bcl2
WO2010094645A1 (en) 2009-02-17 2010-08-26 Neurosearch A/S Substituted pyridine derivatives and their medical use
WO2011051452A1 (en) 2009-10-29 2011-05-05 Palau Pharma, S.A. N-containing heteroaryl derivatives as jak3 kinase inhibitors
WO2012003576A1 (en) 2010-07-06 2012-01-12 Université de Montréal Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators
US8883812B2 (en) * 2010-07-08 2014-11-11 Pfizer Inc. Piperidinyl pyrimidine amides as Kv7 potassium channel openers
MX2013001313A (es) * 2010-08-05 2013-06-13 Amgen Inc Compuestos de bencimidazol y azabencimidazol que inhiben la cinasa del linfoma anaplasico.
EP2970277B1 (en) 2013-03-15 2021-07-28 Knopp Biosciences LLC Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators
SMT202300362T1 (it) * 2014-09-12 2023-11-13 Biohaven Therapeutics Ltd Benzoimidazol-1,2-il-ammidi come attivatori di canale kv7
CA3093976A1 (en) * 2018-03-19 2019-09-26 Michael E. Bozik Kv7 channel activators compositions and methods of use
EP4031548A4 (en) * 2019-09-17 2023-10-18 Knopp Biosciences LLC Methods of use for kv7 channel activators

Also Published As

Publication number Publication date
PT3572405T (pt) 2023-10-26
EP3191457B1 (en) 2019-07-10
US20180148419A1 (en) 2018-05-31
EP3191457A2 (en) 2017-07-19
US20160075663A1 (en) 2016-03-17
US9481653B2 (en) 2016-11-01
HRP20231071T1 (hr) 2024-03-01
WO2018081825A1 (en) 2018-05-03
US10385025B2 (en) 2019-08-20
EP3572405B9 (en) 2023-12-06
US20210188782A1 (en) 2021-06-24
US11834418B2 (en) 2023-12-05
WO2016040952A2 (en) 2016-03-17
US10906877B2 (en) 2021-02-02
ES2749103T3 (es) 2020-03-19
SI3572405T1 (sl) 2023-12-29
US12351559B2 (en) 2025-07-08
US20200002292A1 (en) 2020-01-02
DK3572405T3 (da) 2023-10-16
SMT202300362T1 (it) 2023-11-13
EP3191457A4 (en) 2018-02-07
US20170114022A1 (en) 2017-04-27
EP4289822A2 (en) 2023-12-13
ES2960991T3 (es) 2024-03-07
HUE064331T2 (hu) 2024-03-28
EP4289822A3 (en) 2024-01-24
EP3572405B8 (en) 2023-09-06
US20240300903A1 (en) 2024-09-12
RS64708B1 (sr) 2023-11-30
WO2016040952A3 (en) 2016-05-06
FI3572405T3 (fi) 2023-09-22
DK3191457T3 (da) 2019-10-07
EP3572405B1 (en) 2023-07-26
US9914708B2 (en) 2018-03-13
LT3572405T (lt) 2023-10-25
EP3572405A1 (en) 2019-11-27

Similar Documents

Publication Publication Date Title
SI3572405T1 (sl) Amidi benzoimidazol-1,2-il kot aktivatorji kanalov kv 7
SG11201700351VA (en) Headgear clip arrangement
IL257007A (en) 2-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyridins as bace1 inhibitors
EP3102364B8 (en) Tensioner
ZA201703498B (en) Kcnq2-5 channel activator
GB201521751D0 (en) Novel uses
GB201502252D0 (en) Carrier
AU361320S (en) Hammock
GB2553987B (en) Near isothermal machine
GB201503023D0 (en) Chromosomal instability
GB201401978D0 (en) Hammock
PL3175066T3 (pl) Rolka
GB201509039D0 (en) Near isothermal machine
EP4039224C0 (de) Werkstückträger
GB2557371B (en) Millinery block
GB2540733B (en) Variator
PH32015000976S1 (en) Front-lighted backpack
GB201517950D0 (en) Rucksacks
GB201516198D0 (en) Rucksacks
GB201512740D0 (en) Near isothermal machine
ZA201503816B (en) Tensioning unit
GB201508318D0 (en) Variators
AU358031S (en) Hammock
AU357750S (en) Hammock
AU357767S (en) Hammock